skip to content

Cambridge Cardiovascular

 

The University of Cambridge is ranked the world's second-best university by the Times Higher Education World University Rankings, with a reputation for research excellence across a broad range of disciplines.

The University has identified cardiovascular disease as a major research priority, and this has been endorsed by the recent award of a British Heart Foundation Centre of Research Excellence Award of £6 million over 5 years from 2019 to 2024. 

The Cambridge BHF Centre of Research Excellence (BHF CRE) brings together a wide range of cardiovascular research across the University of Cambridge and its affiliated institutes, including the Wellcome Trust Sanger Institute. We aim to provide the leading cardiovascular research training programme in the UK, and offer opportunities for basic science researchers and clinician scientists, at all career stages.

A list of the Cambridge CRE Investigators is found here.

 

Current Opportunities:

Post-doctoral Research Associate in Cardiovascular Regenerative Medicine

The Wellcome - Medical Research Council Cambridge Stem Cell Institute is an international centre of excellence for stem cell research and regenerative medicine. Scientists in the Institute collaborate to advance our knowledge of various stem cell types and to perform pioneering work in translational research areas, providing the foundation for new medical treatments (https://www.stemcells.cam.ac.uk/).

Applications are invited to join a dynamic team led by Dr Sanjay Sinha (https://www.sinha-lab.org/ and http://www.med.cam.ac.uk/sinha/), working to advance novel stem cell therapies to regenerate damaged hearts. The focus of this exciting project will be on ways to use the regenerative properties of human pluripotent stem cell-derived epicardium and cardiomyocytes for cardiac regeneration and to investigate the underlying molecular mechanisms. The successful applicant will work as part of a larger team incorporating other postdocs, students and technicians.

We have established novel in vitro systems using human ES and iPS cells from which epicardium may be generated (Iyer et al Development 2015;142:1528-41, Gambardella et al Development 2019;146:dev174441) and which provides an ideal platform for studies in cardiovascular regenerative medicine (Bargehr et al Nature Biotech 2019;37:895-906).

You will have a PhD with a strong background in cell and molecular biology and a good publication record. It is essential that you have excellent communication and organisational skills and the ability to work collaboratively. Prior experience with myocardial infarction models in rodents and/or in single cell RNA sequencing will be advantageous.

Closing date for all application is Monday 15th Nov 2021 with interviews scheduled for Friday 3rd Dec 2021 (TBC).

Fixed-term: The funds for this post are funded by the British Heart Foundation until 31 July 2023 in the first instance.

FURTHER INFORMATION HERE

Medicine / Cambridge Stem Cell Institute

Positions are available for scientists to lead a programme of cardiovascular regenerative medicine within the University of Cambridge’s...

Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.

 

We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Tammy Dougan

Cardiovascular Seminars at talks.cam

Cambridge Cardiovascular on You Tube

Follow us on Twitter